Studies conducted by Zhang et al. [51] and Utsumi et al. [52] revealed that a low pre-treatment serum ALB/GLB ratio was independently correlated with worse OS and RFS in HCC patients undergoing curative surgical resection. The gene discussed is ALB; the disease is hepatocellular carcinoma.